0001641172-25-013004 Sample Contracts

UNDERWRITING AGREEMENT between PROPANC BIOPHARMA, INC. And

Underwriting Agreement • May 30th, 2025 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  May 30th, 2025
• Company
  Propanc Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

The undersigned, Propanc Biopharma, Inc. , a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with D. Boral Capital LLC, (hereinafter referred to as “you,” “D. Boral Capital,” or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) to issue and sell an aggregate of [*] shares (“Firm Shares”) of the Company’s common stock, $0.001 par value per share, (“Common Stock”), and at the election of the Representative, up to an additional [*] share(s) of Common Stock (the “Option Shares” and together with the Firm Shares, the “Shares”). The Firm Shares and the Option Shares, are collectively referred to as the “Public Securities.” The offering and sale of the Public Securities contemplated by this Agreement are referred to herein as the “Offering.”